The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.
Complete FcRn dependence for intravenous Ig therapy in autoimmune skin blistering diseases
Open accessAbstract
Numerous mechanisms of action have been proposed for intravenous Ig (IVIG). In this study, we used IgG passive transfer murine models of bullous pemphigoid (BP), pemphigus foliaceus (PF), and pemphigus vulgaris (PV) to test the hypothesis that the effect of IVIG in autoantibody-mediated cutaneous bullous diseases is to accelerate the degradation of pathogenic IgG by saturation of the MHC-like Fc receptor neonatal Fc receptor (FcRn). BP, PF, and PV are organ-specific antibody-mediated diseases in which autoantibodies target the hemidesmosomal antigen BP180 and desmosomal antigens Dsg1 and Dsg3, respectively. Antibodies against BP180, Dsg1, and Dsg3, when injected into neonatal mice, induce the BP, PF, and PV disease phenotypes, respectively. We found that FcRn-deficient mice were resistant to experimental BP, PF, and PV. Circulating levels of pathogenic IgG in FcRn-deficient mice were significantly reduced compared with those in WT mice. Administration of high-dose human IgG (HDIG) to WT mice also drastically reduced circulating pathogenic IgG levels and prevented blistering. In FcRn-deficient mice, no additional protective effect with HDIG was realized. These data demonstrate that the therapeutic efficacy of HDIG treatment in the pemphigus and pemphigoid models is dependent on FcRn. Thus, FcRn is a promising therapeutic target for treating such IgG-mediated autoimmune diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dermatology in General Medicine.
(1987) · Annals of Internal Medicine · doi:10.7326/0003-4819-106-6-923_2 · Cited by 3,794
Fitzpatrick’s Dermatology in General Medicine
(1999) · Heart & Lung · doi:10.1016/s0147-9563(99)70018-x · Cited by 3,233
Immunomodulation of Autoimmune and Inflammatory Diseases with Intravenous Immune Globulin
Kazatchkine, M. D., & Kaveri, S. V. (2001) · New England Journal of Medicine · doi:10.1056/nejmra993360 · Cited by 1,209
van der Meché, F. G. A., Schmitz, P. I. M., & the Dutch Guillain–Barré Study Group* (1992) · New England Journal of Medicine · doi:10.1056/nejm199204233261705 · Cited by 1,143
Dalakas, M. C., Illa, I., Dambrosia, J. M., Soueidan, S. A., Stein, D. P., Otero, C., Dinsmore, S. T., & McCrosky, S. (1993) · New England Journal of Medicine · doi:10.1056/nejm199312303292704 · Cited by 1,136
Anti-inflammatory Activity of IVIG Mediated Through the Inhibitory Fc Receptor
Samuelsson, A., Towers, T. L., & Ravetch, J. V. (2001) · Science · doi:10.1126/science.291.5503.484 · Cited by 1,053
β2-Microglobulin deficient mice lack CD4−8+ cytolytic T cells
Zijlstra, M., Bix, M., Simister, N. E., Loring, J. M., Raulet, D. H., & Jaenisch, R. (1990) · Nature · doi:10.1038/344742a0 · Cited by 1,012
Inhibition of Toxic Epidermal Necrolysis by Blockade of CD95 with Human Intravenous Immunoglobulin
Viard, I., Wehrli, P., Bullani, R., Schneider, P., Holler, N., Salomon, D., Hunziker, T., Saurat, J.-H., Tschopp, J., & French, L. E. (1998) · Science · doi:10.1126/science.282.5388.490 · Cited by 1,005
Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin
(1999) · Transfusion Medicine Reviews · doi:10.1016/s0887-7963(99)80071-6 · Cited by 869
Augmented humoral and anaphylactic responses in FcγRII-deficient mice
Takai, T., Ono, M., Hikida, M., Ohmori, H., & Ravetch, J. V. (1996) · Nature · doi:10.1038/379346a0 · Cited by 826
Brodie, S. E. (1996) · Survey of Ophthalmology · doi:10.1016/s0039-6257(96)80075-0 · Cited by 745
An Fc receptor structurally related to MHC class I antigens
Simister, N. E., & Mostov, K. E. (1989) · Nature · doi:10.1038/337184a0 · Cited by 729 · cited 1×
“Neonatal Fc receptor (FcRn) is a heterodimer of b2-microglobulin (b2m) and a 45-kDa α chain closely related to MHC class I (55).”
BackgroundJunghans, R. P., & Anderson, C. L. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.11.5512 · Cited by 684
Induction of Pemphigus in Neonatal Mice by Passive Transfer of IgG from Patients with the Disease
Anhalt, G. J., Labib, R. S., Voorhees, J. J., Beals, T. F., & Diaz, L. A. (1982) · New England Journal of Medicine · doi:10.1056/nejm198205203062001 · Cited by 663
Liu, Z., Diaz, L. A., Troy, J. L., Taylor, A. F., Emery, D. J., Fairley, J. A., & Giudice, G. J. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116856 · Cited by 591
Cloning and Primary Structural Analysis of the Bullous Pemphigoid Autoantigen BP180
Giudice, G. J., Emery, D. J., & Diaz, L. A. (1992) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12616580 · Cited by 568
Abnormally short serum half‐lives of IgG in β2‐microglobulin‐deficient mice
Ghetie, V., Hubbard, J. G., Kim, J., Tsen, M., Lee, Y., & Ward, E. S. (1996) · European Journal of Immunology · doi:10.1002/eji.1830260327 · Cited by 469
Roopenian, D. C., Christianson, G. J., Sproule, T. J., Brown, A. C., Akilesh, S., Jung, N., Petkova, S., Avanessian, L., Choi, E. Y., Shaffer, D. J., et al. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.7.3528 · Cited by 456
Mechanism of Intravenous Immune Globulin Therapy in Antibody-Mediated Autoimmune Diseases
Yu, Z., & Lennon, V. A. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901213400311 · Cited by 427
Giudice, G. J., Emery, D. J., Zelickson, B. D., Anhalt, G. J., Liu, Z., & Diaz, L. A. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.151.10.5742 · Cited by 387
Clynes, R., Maizes, J. S., Guinamard, R., Ono, M., Takai, T., & Ravetch, J. V. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.1.179 · Cited by 387
Diaz, L. A., Ratrie, H., Saunders, W. S., Futamura, S., Squiquera, H. L., Anhalt, G. J., & Giudice, G. J. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114812 · Cited by 368
Treatment of Refractory Immune Thrombocytopenic Purpura with an Anti-Fcγ-Receptor Antibody
Clarkson, S. B., Bussel, J. B., Kimberly, R. P., Valinsky, J. E., Nachman, R. L., & Unkeless, J. C. (1986) · New England Journal of Medicine · doi:10.1056/nejm198605083141907 · Cited by 365
Story, C. M., Mikulska, J. E., & Simister, N. E. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.6.2377 · Cited by 345
Amagai, M., Karpati, S., Prussick, R., Klaus-Kovtun, V, & Stanley, J. R. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115968 · Cited by 335
Increased clearance of IgG in mice that lack β2‐microglobulin: possible protective role of FcRn
ISRAEL, E. J., WILSKER, D. F., HAYES, K. C., SCHOENFELD, D., & SIMISTER, N. E. (1996) · Immunology · doi:10.1046/j.1365-2567.1996.d01-775.x · Cited by 333
Infusion of Fcγ fragments for treatment of children with acute immune thrombocytopenic purpura
Debré, M., Griscelli, C., Bonnet, M.-C., Carosella, E., Philippe, N., Reinert, P., Vilmer, E., Kaplan, C., Fridman, W. H., & Teillaud, J.-L. (1993) · The Lancet · doi:10.1016/0140-6736(93)92000-j · Cited by 329
Expression of the neonatal Fc receptor, FcRn, on human intestinal epithelial cells
ISRAEL, E. J., TAYLOR, S., WU, Z., MIZOGUCHI, E., BLUMBERG, R. S., BHAN, A., & SIMISTER, N. E. (1997) · Immunology · doi:10.1046/j.1365-2567.1997.00326.x · Cited by 329
Amagai, M., Nishikawa, T., Nousari, H. C., Anhalt, G. J., & Hashimoto, T. (1998) · Journal of Clinical Investigation · doi:10.1172/jci3647 · Cited by 312
Bruhns, P., Samuelsson, A., Pollard, J. W., & Ravetch, J. V. (2003) · Immunity · doi:10.1016/s1074-7613(03)00080-3 · Cited by 304
Treatment of systemic vasculitis with pooled intravenous immunoglobulin
Jayne, D. R. W., Lockwood, C. M., Davies, M. J., Fox, C. J. V., & Black, C. M. (1991) · The Lancet · doi:10.1016/0140-6736(91)92797-6 · Cited by 297
The role of complement in experimental bullous pemphigoid.
Liu, Z., Giudice, G. J., Swartz, S. J., Fairley, J. A., Till, G. O., Troy, J. L., & Diaz, L. A. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117826 · Cited by 296
Stanley, J. R. (1993) · Advances in Immunology · doi:10.1016/s0065-2776(08)60503-9 · Cited by 262
A major role for neutrophils in experimental bullous pemphigoid.
Liu, Z., Giudice, G. J., Zhou, X., Swartz, S. J., Troy, J. L., Fairley, J. A., Till, G. O., & Diaz, L. A. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119639 · Cited by 250
Antigen-Specific Immunoadsorption of Pathogenic Autoantibodies in Pemphigus Foliaceus
Amagai, M., Hashimoto, T., Green, K. J., Shimizu, N., & Nishikawa, T. (1995) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12606168 · Cited by 241
Mast cells play a key role in neutrophil recruitment in experimental bullous pemphigoid
Chen, R., Ning, G., Zhao, M.-L., Fleming, M. G., Diaz, L. A., Werb, Z., & Liu, Z. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11494 · Cited by 232
Sawamura, D., Li, K., Chu, M., & Uitto, J. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)55195-4 · Cited by 222
Nguyen, V. T., Ndoye, A., & Grando, S. A. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64651-2 · Cited by 218
Mechanisms of action of intravenous immune globulin in immune-mediated diseases
Mouthon, L., Kaveri, S. V., Spalter, S. H., Lacroix-Desmazes, S., Lefranc, C., Desai, R., & Kazatchkine, M. D. (2019) · Clinical and Experimental Immunology · doi:10.1111/cei.1996.104.s1.3 · Cited by 202
Brazilian Pemphigus Foliaceus Autoantibodies Are Pathogenic to BALB/c Mice by Passive Transfer
Roscoe, J. T., Diaz, L., Sampaio, S. A. P., Castro, R. M., Labib, R. S., Takahashi, Y., Patel, H., & Anhalt, G. J. (1985) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12277362 · Cited by 197
The MHC class I–like Fc receptor promotes humorally mediated autoimmune disease
Akilesh, S., Petkova, S., Sproule, T. J., Shaffer, D. J., Christianson, G. J., & Roopenian, D. (2004) · Journal of Clinical Investigation · doi:10.1172/jci18838 · Cited by 196
HIGH-DOSE INTRAVENOUS GAMMAGLOBULIN FOR MYASTHENIA GRAVIS
Gajdos, P., Outin, H., Elkharrat, D., Brunel, D., de Rohan-Chabot, P., Raphael, J. C., Goulon, M., Goulon-Goeau, C., & Morel, E. (1984) · The Lancet · doi:10.1016/s0140-6736(84)90469-0 · Cited by 195
Li, N., Aoki, V., Hans-Filho, G., Rivitti, E. A., & Diaz, L. A. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20022031 · Cited by 191
Self-citationPemphigus and bullous pemphigoid
Nousari, H. C., & Anhalt, G. J. (1999) · The Lancet · doi:10.1016/s0140-6736(99)03007-x · Cited by 188
Hansen, R., & Balthasar, J. (2002) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1613331 · Cited by 164
Mechanisms of action of intravenous immune serum globulin in autoimmune and inflammatory diseases
Ballow, M. (1997) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(97)70217-3 · Cited by 163
Isolation and characterization of the Fc receptor from the fetal yolk sac of the rat.
Roberts, D. M., Günthert, M., & Rodewald, R. (1990) · The Journal of Cell Biology · doi:10.1083/jcb.111.5.1867 · Cited by 153
Pemphigus Vulgaris Antibody Identifies Pemphaxin
Nguyen, V. T., Ndoye, A., & Grando, S. A. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m003174200 · Cited by 132
Hansen, R. J., & Balthasar, J. P. (2002) · Blood · doi:10.1182/blood.v100.6.2087 · Cited by 126
The Role of Subclass Switching in the Pathogenesis of Endemic Pemphigus Foliaceus
Warren, S., Arteaga, L. A., Diaz, L. A., Rivitti, E. A., Aoki, V., Filho, G. H., Qaqish, B. F., Lin, M., & Giudice, G. J. (2003) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2003.12017.x · Cited by 126
Crow, A. R., Song, S. M., Semple, J. W., Freedman, J. J., & Lazarus, A. H. (2001) · British Journal of Haematology · doi:10.1046/j.1365-2141.2001.03136.x · Cited by 115
Siragam, V., Brinc, D., Crow, A. R., Song, S. M., Freedman, J. J., & Lazarus, A. H. (2005) · Journal of Clinical Investigation · doi:10.1172/jci22753 · Cited by 110
Bleeker, W. K., Teeling, J. L., & Hack, C. E. (2001) · Blood · doi:10.1182/blood.v98.10.3136 · Cited by 99
Christianson, G. J., Brooks, W., Vekasi, S., Manolfi, E. A., Niles, J., Roopenian, S. L., Roths, J. B., Rothlein, R., & Roopenian, D. C. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.159.10.4781 · Cited by 98
Tóth, G. G., & Jonkman, M. F. (2001) · Clinics in Dermatology · doi:10.1016/s0738-081x(00)00190-5 · Cited by 69
Masson, P. L. (1993) · Journal of Autoimmunity · doi:10.1006/jaut.1993.1057 · Cited by 67
Localization of the site of the IgG molecule that regulates maternofetal transmission in mice
Medesan, C., Radu, C. G., Kim, J.-K., Ghetie, V. F., & Ward, E. S. (1996) · European Journal of Immunology · doi:10.1002/eji.1830261038 · Cited by 57
Soubrane, C., Tourani, J. M., Andrieu, J., Visonneau, S., Beldjord, K., Israël‐Biet, D., Mouawad, R., Bussel, J. B., Weil, M., & Khayat, D. (1993) · Blood · doi:10.1182/blood.v81.1.15.15 · Cited by 54
β2-microglobulin–deficient Mice Are Resistant to Bullous Pemphigoid
Liu, Z., Roopenian, D. C., Zhou, X., Christianson, G. J., Diaz, L. A., Sedmak, D. D., & Anderson, C. L. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.5.777 · Cited by 48
Inhibitory Fc Gamma Receptors: From Gene to Disease
Stefanescu, R. N., Olferiev, M., Liu, Y., & Pricop, L. (2004) · Journal of Clinical Immunology · doi:10.1023/b:joci.0000029105.47772.04 · Cited by 42
Mast cells play a key role in neutrophil recruitment in experimental bullous pemphigoid
Chen, R., Ning, G., Zhao, M., Fleming, M. G., Diaz, L. A., Werb, Z., & Liu, Z. (2001) · Journal of Clinical Investigation · doi:10.1172/jci200111494 · Cited by 19
Expression of host defense scavenger receptors in spondylarthropathy
McBeth (2001) · Pure Amsterdam UMC · doi:10.1002/1529-0131(200104)44:4 · Cited by 1
Cited by
FcRn: the neonatal Fc receptor comes of age
Roopenian, D. C., & Akilesh, S. (2007) · Nature Reviews Immunology · doi:10.1038/nri2155 · Cited by 2,346
IgG placental transfer in healthy and pathological pregnancies
Palmeira, P., Quinello, C., Silveira-Lessa, A. L., Zago, C. A., & Carneiro-Sampaio, M. (2012) · Clinical and Developmental Immunology · doi:10.1155/2012/985646 · Cited by 1,037
Intravenous immunoglobulin therapy: how does IgG modulate the immune system?
Schwab, I., & Nimmerjahn, F. (2013) · Nature Reviews Immunology · doi:10.1038/nri3401 · Cited by 820
Mouse and human FcR effector functions
Bruhns, P., & Jönsson, F. (2015) · Immunological Reviews · doi:10.1111/imr.12350 · Cited by 579
Anti-Inflammatory Actions of Intravenous Immunoglobulin
Nimmerjahn, F., & Ravetch, J. V. (2008) · Annual Review of Immunology · doi:10.1146/annurev.immunol.26.021607.090232 · Cited by 525
Metadata
- Authors
- Li, N.
- Venue
- Journal of Clinical Investigation
- Published
- 2005-12-01
- Volume
- 115
- Issue
- 12
- Pages
- 3440-3450
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2144759405
- Cited by
- 264
- References
- 62
- FWCI
- 8.31
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.